focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Jefferies Upgrades Lloyds To Hold

Wed, 01st Apr 2015 08:42

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning:
----------
FTSE 100
----------
MORGAN STANLEY RAISES EASYJET TARGET TO 1,940 (1,770) PENCE - 'OVERWEIGHT'
----------
LIBERUM RAISES WPP PRICE TARGET TO 1585 (1280) PENCE - 'HOLD'

CITIGROUP RAISES GKN PRICE TARGET TO 420 (390) PENCE - 'BUY'
----------
JPMORGAN CUTS RIO TINTO PRICE TARGET TO 3500 (3550) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1690 (1720) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 650 (710) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES FRESNILLO PRICE TARGET TO 1250 (1180) PENCE - 'OVERWEIGHT'
----------
NOMURA CUTS KINGFISHER PRICE TARGET TO 305 (315) PENCE - 'NEUTRAL'
----------
NOMURA CUTS VODAFONE PRICE TARGET TO 185 (190) PENCE - 'REDUCE'
----------
NOMURA CUTS DIAGEO PRICE TARGET TO 1930 (1980) PENCE - 'NEUTRAL'
----------
JEFFERIES RAISES LLOYDS TO 'HOLD' ('UNDERPERFORM') - PRICE TARGET 88 (69) PENCE
----------
BARCLAYS RAISES SHIRE PRICE TARGET TO 5564 (5055) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1840 (1690) PENCE - 'OVERWEIGHT'
----------
BARCLAYS RAISES ASTRAZENECA PRICE TARGET TO 4770 (4400) PENCE - 'UNDERWEIGHT'
----------
TRADERS: HSBC RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 650 (610) PENCE
----------
TRADERS: HSBC RAISES PERSIMMON PRICE TARGET TO 1920 (1880) PENCE
----------
FTSE 250
----------
PANMURE CUTS FIRSTGROUP PRICE TARGET TO 120 (140) PENCE - 'BUY'
----------
CITIGROUP RAISES POLYMETAL PRICE TARGET TO 523 (487) PENCE - 'SELL'
----------
JPMORGAN CUTS VEDANTA PRICE TARGET TO 490 (520) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS RPC GROUP PRICE TARGET TO 700 (710) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 290 (320) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES ACACIA MINING PRICE TARGET TO 360 (350) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES PROVIDENT TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 3100 (2700) P.
----------
NOMURA CUTS THOMAS COOK PRICE TARGET TO 135 (139) PENCE - 'NEUTRAL'
----------
EXANE BNP RAISES HAYS PRICE TARGET TO 190 (180) PENCE - 'OUTPERFORM'
----------
TRADERS: HSBC RAISES BERKELEY GROUP PRICE TARGET TO 2900 (2835) PENCE
----------
TRADERS: HSBC RAISES BOVIS HOMES PRICE TARGET TO 1340 (1310) PENCE
----------
TRADERS: HSBC RAISES CREST NICHOLSON PRICE TARGET TO 660 (625) PENCE
----------
TRADERS: HSBC RAISES GALLIFORD TRY PRICE TARGET TO 1975 (1770) PENCE
----------
TRADERS: HSBC RAISES REDROW PRICE TARGET TO 440 (415) PENCE
----------
TRADERS: HSBC RAISES BALFOUR BEATTY PRICE TARGET TO 285 (185) PENCE
----------
GOLDMAN RAISES PENNON GROUP PRICE TARGET TO 795 (771) PENCE - 'SELL'
----------
UBS RAISES CAIRN ENERGY TO 'BUY' ('NEUTRAL') - TARGET 195 PENCE
----------
TRADERS: HSBC RAISES BELLWAY PRICE TARGET TO 2815 (2620) PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.